logo-loader
viewCronos Group Inc

Cronos Group reports higher revenue but widening loss in mixed 4Q earnings results

In March, the Canadian cannabis producer closed a $2.4 billion investment from Marlboro cigarette maker Altria Inc

cannabis plant
The Toronto-based company attributed revenue growth for the quarter to shipments to the Canadian adult-use market and a growth in cannabis oil proceeds

Cronos Group Inc (NASDAQ:CRON) (TSE:CRON) saw revenue rise in the fourth quarter of 2018 but still reported a net loss for the period as it released its quarterly and year-end earnings early Tuesday.

Shares of Cronos slipped more than 3% in morning trading as the Canadian cannabis producer reported 4Q revenue of US$5.6 million, significantly higher than the $1.6 million for the same period last year.

However, the company still had a net loss of $11.6 million during the quarter, or $0.06 per share. The cannabis producer swung from a profit of a penny per share in the year-ago quarter.

The Toronto-based company attributed revenue growth for the quarter to shipments to the Canadian adult-use market and a growth in cannabis oil proceeds.

READ: Altria makes C$2.4B investment in Canadian cannabis company Cronos Group

Analysts were expecting to see a loss of $0.01 on earnings of $7.8 million for the quarter. Cronos missed on both metrics.

Full-year revenue for 2018 was C$19.2 million, compared with C$1.8 million in 2017 but, again, a net loss of C$0.11 per share versus a penny profit a year ago. 

“Over the past year, Cronos Group has diligently focused on our strategic objectives, which culminated in our transformative partnership with Altria Group, Inc.,” said Mike Gorenstein, CEO of Cronos Group. “We’ve expanded our production footprint domestically and internationally, developed our distribution with global partnerships, launched iconic brands for the Canadian adult-use market and grown our IP portfolio with landmark research and development initiatives.”

In March 2019, Cronos closed a $2.4 billion equity investment from Marlboro cigarette maker Altria Inc. Altria now holds 45% of Cronos shares, with an option to increase its stake to 55% under the agreement.

Shares of Cronos were trading at US$19.80 in New York and slipped 1% to C$27.10 in Toronto on Tuesday morning.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

 

Quick facts: Cronos Group Inc

Price: 6.46 USD

NASDAQ:CRON
Market: NASDAQ
Market Cap: $2.25 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

archTIS poised for strong growth as they look at multiple sectors for technology

archTIS LTD (ASX: AR9) CEO and Executive Director Daniel Lai joined Steve Darling from Proactive to share his direction for the company as they look to branch out with their technology. Lai telling Proactive some of the contracts they have signed including their first in the Education/Space...

8 hours, 25 minutes ago

2 min read